García-Matte Raimundo J, Beltran M Constanza, Fonseca Ximena, Barriga Francisco, Wietstruck Angélica, Zúñiga Pamela
Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Acta Otorrinolaringol Esp. 2012 Mar-Apr;63(2):115-9. doi: 10.1016/j.otorri.2011.09.007. Epub 2011 Dec 6.
Adenotonsillar surgery represents a major haemostatic challenge in paediatric patients with mild inherited platelet dysfunction. While there are recommendations for perioperative haemostatic management, there are no reports of the outcomes with the different recommendations in these children when undergoing adenotonsillectomy. Our objective was to evaluate the management of perioperative bleeding with desmopressin in children with mild platelet dysfunctions who underwent adenotonsillar surgery in our hospital.
We performed a retrospective study aimed at determining the perioperative bleeding and complication rate in children with mild inherited platelet dysfunction in whom desmopressin was used while undergoing adenotonsillar procedures.
Between 2004 and 2010, 27 children with mild inherited platelet dysfunction underwent adenotonsillar procedures in our hospital and were treated with desmopressin. One patient developed perioperative bleeding (3.7%) and there was 1 child (3.7%) who presented transitory hypotension as a side effect of desmopressin.
The use of desmopressin allowed adequate perioperative bleeding prophylaxis management in children with mild inherited platelet dysfunction who underwent adenotonsillar procedures without presenting severe complications.
对于患有轻度遗传性血小板功能障碍的儿科患者,腺样体扁桃体手术是一项重大的止血挑战。虽然有围手术期止血管理的建议,但对于这些儿童在接受腺样体扁桃体切除手术时,不同建议的结果尚无报道。我们的目的是评估在我院接受腺样体扁桃体手术的轻度血小板功能障碍儿童中,使用去氨加压素进行围手术期出血管理的情况。
我们进行了一项回顾性研究,旨在确定在接受腺样体扁桃体手术过程中使用去氨加压素的轻度遗传性血小板功能障碍儿童的围手术期出血和并发症发生率。
2004年至2010年期间,我院有27例患有轻度遗传性血小板功能障碍的儿童接受了腺样体扁桃体手术,并接受了去氨加压素治疗。1例患者出现围手术期出血(3.7%),1名儿童(3.7%)出现作为去氨加压素副作用的短暂性低血压。
对于接受腺样体扁桃体手术的轻度遗传性血小板功能障碍儿童,使用去氨加压素可实现充分的围手术期出血预防管理,且未出现严重并发症。